2011156
print

Primary Antibody Deficiency Panel, Sequencing and Deletion/Duplication

PAD PANEL
Example Reports
Negative
Positive

Icon

Informed Consent for Genetic Testing (Required for NY patients)

Icon

Patient History for Primary Antibody Deficiency Genetic Testing

Icon

Additional Technical Information

Ordering Recommendation

Use to determine the genetic etiology of disease in individuals with a suspected or confirmed diagnosis of a primary antibody deficiency (eg, agammaglobulinemia, hyper-IgM syndrome, or common variable immunodeficiency). This test does not analyze B-cell expression or immunoglobulin levels and is not recommended for individuals who have not had previous clinical testing for immunodeficiencies.

New York DOH Approval Status

Testing is not New York state approved. Specimens from New York clients will be sent out to a New York state-approved laboratory.

Specimen Required

Patient Preparation
Collect

Lavender or pink (EDTA) or yellow (ACD solution A or B).

Specimen Preparation

Transport 3 mL whole blood. (Min: 3 mL)
New York State Clients: 5 mL (Min: 3 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Serum or plasma; grossly hemolyzed or frozen specimens; saliva, buccal brush, or swab; FFPE tissue.

Remarks
Stability

Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
New York State Clients: Ambient: 48 hours; Refrigerated: 1 week; Frozen: Unacceptable

Methodology

Massively Parallel Sequencing/Sequencing

Performed

Varies

Reported

14-21 days

Reference Interval

By report

Interpretive Data

Refer to report.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Compliance Category

Laboratory Developed Test (LDT)

Note

Genes Tested: ADA; ADA2; AICDA; ATM; ATP6AP1; BLNK; BTK; CARD11; CD19; CD27; CD40; CD40LG; CD70; CD79A; CD79B; CDCA7; CR2; CTLA4; CXCR4*; DCLRE1C*; DNMT3B; GATA2; HELLS; ICOS; IGHM; IGLL1; IKZF1; IL21R; KDM6A; KMT2D; LRBA; MOGS; MS4A1; NBN; NFKB1; NFKB2; NFKBIA**; PIK3CD;  PIK3R1; PLCG2; PRKCD; RAC2; RAG1; RAG2; RNF168; SH2D1A; STAT3; TCF3**; TNFRSF13B; TRNT1; TTC37; UNG; XIAP*; ZBTB24
 
*One or more exons are not covered by sequencing for the indicated gene; see limitations section below.
**Deletion/duplication analysis is not available for this gene.

Hotline History

N/A

CPT Codes

81403; 81404; 81405; 81406; 81408; 81479

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
2011220 Primary Antibody Deficiency Specimen 31208-2
2011223 Primary Antibody Deficiency Panel Interp
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Late-onset combined immunodeficiency
  • HIGM1
  • HIGM2
  • Hypogammaglobulinemia
  • Immunoglobulin class-switch deficiency
  • CD45
  • Common variable hypogammaglobulinemia
  • Common variable immune deficiency
  • Recurrent infections
  • HIGM5
  • Hyper-IgM syndrome
  • CD21
  • Selective IgA deficiency
  • Selective IgM deficiency
  • Late-onset immunoglobulin deficiency
  • NEMO
  • HIGM3
  • HIGM4
  • TACI
  • Common variable immunodeficiency
  • Genetic antibody deficiency
  • HIGM syndrome
  • Lambda-5
  • CD20
  • IgG subclass deficiency
  • CVID
  • Agammaglobulinemia
  • Anti-polysaccharide antibody deficiency
  • Autoimmune conditions
  • B-cell deficiency
  • BAFFR
  • IgG deficiency
  • Selective antibody deficiency
  • IgA deficiency
  • Panhypogammaglobulinemia
Primary Antibody Deficiency Panel, Sequencing and Deletion/Duplication